Related Experiment Video
Updated: May 19, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
Toxic megacolon from fulminant Clostridium difficile infection induced by topical silver sulphadiazine
Christopher B Tan1, Dhyan Rajan, Mitanshu Shah
1Department of Internal Medicine, Nassau University Medical Center, East Meadow, New York, USA. ctan@numc.edu
Abstract:
Pseudomembranous colitis and toxic megacolon (TM) are well-known complications of Clostridium difficile infections. Systemic antibiotic is considered as the major risk factor for the development of C difficile colitis. However, topical antibiotics are rarely associated with the infection. As previously thought, the use of topical antibiotic is capable of systemic absorption in damaged and denuded skin; sufficient enough to suppress the normal bowel flora. Here, we present an unusual case of TM from C difficile infection induced by topical silver sulphadiazine in a 60-year-old man with immune-bullous pemphigus vulgaris. The diagnosis is further complicated by the absence of diarrhoea as the initial presentation. Despite adequate medical and surgical intervention, the patient had an unfavourable outcome.
Insights
Topical antibiotics, like silver sulphadiazine, can rarely cause Clostridium difficile infection leading to toxic megacolon (TM). This case highlights an unusual presentation of TM without initial diarrhea.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Dermatology
Background:
- Clostridium difficile infection (CDI) commonly leads to pseudomembranous colitis and toxic megacolon (TM).
- Systemic antibiotics are the primary risk factor for CDI, while topical antibiotic association is rare.
- Topical antibiotics can be systemically absorbed through damaged skin, potentially altering gut flora.
Observation:
- A 60-year-old male with immune-bullous pemphigus vulgaris developed toxic megacolon (TM).
- The TM was attributed to Clostridium difficile infection (CDI) triggered by topical silver sulphadiazine.
- The patient's initial presentation lacked diarrhea, complicating the diagnosis.
Findings:
- Topical silver sulphadiazine use was linked to the development of C. difficile-induced toxic megacolon (TM).
- The absence of diarrhea as an initial symptom presented a diagnostic challenge.
- Despite comprehensive medical and surgical management, the patient experienced an unfavorable outcome.
Implications:
- This case underscores the potential for topical antibiotics to induce severe gastrointestinal complications like TM.
- Clinicians should consider CDI in patients with toxic megacolon, even with unusual presentations or topical antibiotic exposure.
- Further research into the systemic absorption and effects of topical antimicrobials on gut microbiota is warranted.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Staphylococcal Skin Infections
Inflammatory Bowel Disease II: Ulcerative Colitis
Clinical Significance of Antibiotic Resistance
Drugs for Treatment of Ulcerative Colitis in IBD
Prevention of Further Absorption of Poison

